Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon Endo-Surgery said today that it paid an unspecified amount for Megadyne Medical Products, 4 years after inking a collaboration deal with the electrosurgical tools maker .
“We are committed to meeting the evolving needs of surgeons and hospital systems, and the addition of Megadyne’s state-of-the-art portfolio gives us a comprehensive suite of energy devices to improve patient care in surgeries across all specialties,” Ethicon chairman Michael del Prado said in prepared remarks. “This acquisition will help accelerate and expand innovation across the entire energy portfolio, broadening our surgical and energy solutions to provide clinical and economic value to customers worldwide.”
“Megadyne shares Ethicon’s commitment to bringing innovative solutions to surgeons and hospital systems worldwide,” added Megadyne CEO Rob Farnsworth. “We are excited about working together to bring more elegant electrosurgical tools to a broader market through Ethicon’s extended global network.”
Back in 2013, the companies joined forces to market a combined portfolio of energy-based surgical devices using Megadyne’s monopolar and bipolar devices and Ethicon’s advanced bipolar and ultrasonic energy devices.